11 Jul 2006 -
RNAx GmbH announced a co-exclusive multi-year strategic alliance with VWR for sales representation of the company's automated RNAi validation services. Customers in Europe will now be able to access industry leading, automated si- and shRNA validation services at RNAx via their local VWR specialist service representative. VWR's sales and marketing operation currently serves over 250,000 customers with an extensive worldwide specialist sales network.
Jörg Pötzsch, CEO at RNAx commented "This alliance with VWR marks the start of a new quality of visibility and market penetration for RNAx. With the experienced team of VWR's sales representatives we will be able to target many more researchers, and generate substantially more leads than we would ever have been able to do alone, even by investing in extending our own business development team. Ten years of business experience and knowledge of the biosciences markets at VWR are now put at RNAx' service. This is of extremely high value for us. We are excited to have been chosen by one of the largest corporations to be one of the first service providers in the new VWR BioSciences programme. This alliance is another proof for the quality and reliability of RNAx' services, and truly marks a new step in RNAx' corporate development."
Zishan Haroon, CEO of VWR Biosciences commented "The BioSciences programme extends above and beyond VWR's traditional role by providing research services for our customers, drug discovery and development needs. Establishing a partnership with RNAx helps accomplish exactly this, offering an industry leader in RNAi technologies to our customers. RNAx a highly reputable firm, delivering the highest quality services with the utmost efficiency. Our commitment to excellence ensures that the researcher can have the highest confidence in the value RNAx provides."
Top
Contact
Print version
PDF version
Send article
RSS feed
analytica
analytica China
analytica Vietnam
analytica Anacon